Market Research Life Sciences Market Research Medical Devices Market Research Infusion Products Market Research

Germany Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis

Best Price Guarantee Length Publisher Published Date SKU
from $2,990 190 Pages Renub Research March, 2023 RNBR17831876
Best Price Guarantee
Price from $2,990
Length 190 Pages
Publisher Renub Research
Published Date March, 2023
SKU RNBR17831876

Germany Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis

Germany Diabetes Market is expected to be USD 30.4 Billion in 2028, registering a CAGR of 5.92% during the forecast period, 2023-2028, according to Renub Research. Germany has one of the highest diabetes in the European region. The number of type 2 diabetes people will continue to increase over the next twenty years. The German Diabetes Centre (DDZ) estimates that up to 12 Million people might suffer from metabolic disorders in 2040. The substantial increase in incidence not only of type 2 diabetes in the aging population but also of type 1 diabetes will present significant challenges to the German health system in the coming years. Currently, mortality rates among people with diabetes in Germany are about twice as high as those without diabetes.

Leading manufacturers focuses on technological innovations and developing advanced products to gain a substantial market share. There has been a significant rise in insulin delivery systems technology, ranging from insulin injections to insulin pumps. Technological innovations and advancements offer many conveniences in maintaining blood glucose levels. Therefore, owing to the increasing diabetes prevalence, the German diabetes market is anticipated to witness growth over the upcoming years. As a result Germany Diabetes Market was valued at US$ 21.51 Billion in 2022.

Number of Older Adults with Type 2 Diabetes is Increasing Particularly Rapidly

Diabetes is a major health problem and one of the massive challenges for German healthcare systems. The prevalence of 1 & 2 type diabetes in the German adult population is very high, along with an increasing number of undiagnosed patients. Factors to an unhealthy lifestyle and an aging population, the prevalence of type 2 diabetes are expected to increase more over the upcoming years. High-quality care, including adequate monitoring, active self-management, and control of risk factors, is critical for preventing complications of type 2 diabetes in German patients.

Furthermore, the rate of newly diagnosed Type 1 and 2 diabetes cases is seen to increase, mainly due to obesity, unhealthy diet, and physical inactivity. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure are indications of the increasing usage of diabetic care drugs.

Insulin Pen will create more demand in Germany

Germany Diabetic market is segmented into four parts; Insulin Pen, Continuous Glucose Monitoring (CGM) Device, Self Monitoring Blood Glucose (SMBG) Device, and Insulin Pump. All four insulin delivery devices segment mentioned above are growing year on year. Insulin pen will hold significant market demand in upcoming years. Insulin pens are gaining popularity due to their unique features, such as easy to carry, user-friendly design, and ease of usage. With the rising incidences of diabetic problems, various digital care solutions have been introduced to help people with diabetes.

In recent years, Germany has witnessed an alarming increase in the prevalence of diabetes. Patients with diabetes require many daily corrections to maintain nominal blood glucose levels, such as SMBG and CGM, by monitoring their blood glucose levels. Over the past decade, the utilization of diabetes technology, such as insulin pumps and continuous glucose monitors (CGMs), for the management of pediatric type 1 diabetes has increased in Germany. For instance, In Oct 2022, Mediq, a comprehensive European, announced to acquisition DiaExpert, a diabetes specialist and mail-order company for diabetes supplies in Germany, currently part of the Ypsomed Group.

German Government Initiative

Germany diabetes pandemic emerged quickly enough to challenge health services and was gradually sufficient to give the impression that minor changes would be enough to cope with the rising burden. German law planned to cap out-of-pocket healthcare costs and to cover all medically necessary treatment, including insulin drugs, for the public. As a result, German diabetes patients have some of the lowest out-of-pocket expenses in the world.

Germany diabetes is a significant health problem and one of the astounding challenges for healthcare systems. The growing incidence, prevalence, and progressive nature of the disease have encouraged the development of new drugs to provide additional treatment options for diabetic patients. Many newly launched products, increasing awareness about diabetes among people, and increasing international research collaborations in technology advancement are the main opportunities for the players in the German diabetes drugs market.

Key Players

Some of the prominent market players are B. Braun Melsungen AG, Eli Lilly, and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nordisk, Ypsomed AG, Medtronic, Insulet Corporation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic,Tandem Diabetes Care.

In April 2022, CamDiab, Abbott, and Ypsomed partnered to develop and market an integrated automated insulin delivery (AID) system, which helps to decrease the burden of people with diabetes. The main focus of this partnership will be on European countries.
In June 2022, Abbott announced that it was developing a new bio-wearable for continuously monitoring glucose and ketone levels in one sensor.

Renub Research report titled “Germany Diabetes Market, By Self-Monitoring Blood Glucose Device (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Insulin Pen (Disposable, Reusable & Smart Insulin Pen, Needle Market, Reimbursement Policies), Insulin Pump Market, (Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP) Companies (B. Braun Melsungen AG, Eli Lilly, and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nordisk, Ypsomed AG, Medtronic, Insulet Corporation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic and Tandem Diabetes Care)” provides a complete analysis of Germany Insulin Devices Market.

Segments Market based on Devices

1. Continuous Glucose Monitoring (CGM)
2. Self-Monitoring Blood Glucose (SMBG)
3. Insulin Pen
4. Insulin Pump

Germany Diabetes Sub-Segment Analysis

1. Continuous Glucose Monitoring (CGM)

1. Glucose Sensor Market & Forecast
2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement

2. SMBG

1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement

3. Insulin Pen Market

1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Insulin Pen Users
6. Reimbursement Policies

4. Insulin Pump Market

1. Insulin Pump Market
2. Insulin Pump Users
3. Insulin Pump Products
4. Reimbursement Policies

All the 13 Companies Studied in the Report have been Studied from 3 Points

• Company Overview
• Recent Developments
• Financial Insight

Company Analysis

1. B. Braun Melsungen AG
2. Eli Lilly, and Company
3. Terumo Corporation
4. Becton, Dickinson (BD)
5. Novo Nordisk
6. Ypsomed AG
7. Medtronic
8. Insulet Corporation
9. Abbott Laboratories
10. DarioHealth Crop
11. Dexcom, Inc
12. Roche Diagnostic
13. Tandem Diabetes Care


1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Germany Diabetes Market
6. Germany Diabetes Population
6.1 Type 1 Diabetes Population
6.1 Type 2 Diabetes Population
7. Market Share –Germany Diabetes Market
7.1 By Types
8. Continuous Glucose Monitoring Market (CGM) – Germany Market & Users
8.1 Germany- CGM Market by Components
8.1.1 Glucose Sensor Market & Forecast
8.1.2 CGM Transmitter Market & Forecast
8.2 Germany– CGM User
8.3 CGM Reimbursement in Germany
9. Blood Glucose Device (SMBG) – Germany Market & Users
9.1 SMBG Market
9.1.1 Type 1 Diabetes
9.1.2 Type 2 Diabetes
9.2 Test Strips Market and Forecast
9.2.1 Type 1 Diabetes
9.2.2 Type 2 Diabetes
9.3 Lancet Market and Forecast
9.3.1 Type 1 Diabetes
9.3.2 Type 2 Diabetes
9.4 Meter Market and Forecast
9.4.1 Type 1 Diabetes
9.4.2 Type 2 Diabetes
9.5 Blood Glucose Device (SMBG) Users
9.5.1 Type 1 Diabetes
9.5.2 Type 2 Diabetes
9.6 Reimbursement of Blood Glucose Devices in Germany
10. Insulin Pen - Germany Market & User Analysis
10.1 Insulin Pen Market
10.1.1 Disposable Insulin Pen Market
10.1.2 Reusable Insulin Pen Market
10.1.3 Smart Insulin Pen Market
10.2 Insulin Pen User
10.2.1 Disposable Insulin Pen User
10.2.2 Reusable Insulin Pen User
10.2.3 Smart Insulin Pen User
10.3 Insulin Pen Needle Market
10.4 Reimbursement Policies
11. Insulin Pump - Germany Market & User Analysis
11.1 Insulin Pump Market
11.1.1 Type 1
11.1.1 Type 2
11.2 Insulin Pump User
11.2.1 Type 1
11.2.1 Type 2
11.3 Differentiation Points of Insulin Pump Products in Germany
11.3.1 Animas Vibe
11.3.2 Medtronic 530G with Enlite
11.3.3 Insulet OmniPod
11.3.4 Tandem t: slim
11.3.5 Roche Accu-Chek Combo
11.4 Training Model for Patients & HCP – of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care
11.4.1 Medtronic
11.5 Insulet Corporation
11.5.1 Training Structure for New Patients - Insulet Corporation
11.6 Animas Corporation
11.6.1 Training Modules for New Patients
11.6.2 Training Modules for HCP (Health Care Professional)
11.7 Tandem Diabetes Care
11.8 Reimbursement Policies on Insulin Pump
12. Insulin Pen – Company Analysis
12.1 B. Braun Melsungen AG
12.1.1 Overview
12.1.2 Recent Developments
12.1.3 Revenue
12.2 Eli Lilly
12.2.1 Overview
12.2.2 Recent Developments
12.2.3 Revenue
12.3 Terumo Corporation
12.3.1 Overview
12.3.2 Initiatives & Recent Developments
12.3.3 Revenue
12.4 Becton, Dickinson (BD)
12.4.1 Overview
12.4.2 Recent Developments
12.4.3 Revenue
12.5 Novo Nordisk A/S
12.5.1 Overview
12.5.2 Initiatives & Recent Developments
12.5.3 Revenue
12.6 Ypsomed AG
12.6.1 Overview
12.6.2 Recent Developments
12.6.3 Revenue
13. Insulin Pump – Company Analysis
13.1 Medtronic
13.1.1 Overview
13.1.2 Recent Developments
13.1.3 Revenue
13.2 Insulet Corporation
13.2.1 Overview
13.2.2 Recent Developments
13.2.3 Revenue
14. SMBG – Company Analysis
14.1 DarioHealth Corp
14.1.1 Overview
14.1.2 Revenue
14.2 Abbott Laboratories
14.2.1 Overview
14.2.2 Revenue
15. CGM – Company Analysis
15.1 Dexcom Inc
15.1.1 Overview
15.1.2 Recent Developments
15.1.3 Revenue
15.2 Roche
15.2.1 Overview
15.2.2 Recent Developments
15.2.3 Revenue
15.3 Tandem Diabetes Care
15.3.1 Overview
15.3.2 Recent Developments
15.3.3 Revenue
List of Figures:
Figure-01: Germany – Diabetes Market (Billion US$), 2017 – 2022
Figure-02: Germany – Forecast for Diabetes Market (Billion US$), 2023 – 2028
Figure-03: Germany – Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure-04: Germany – Forecast for Type 1 Diabetes Population (Thousand), 2023 – 2028
Figure-05: Germany – Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure-06: Germany – Forecast for Type 2 Diabetes Population (Thousand), 2023 – 2028
Figure-07: Germany – Glucose Sensor Market Market (Million US$), 2017 – 2023
Figure-08: Germany – Forecast for Glucose Sensor Market Market (Million US$), 2023 – 2028
Figure-09: Germany – CGM Transmitter Market Market (Million US$), 2017 – 2023
Figure-10: Germany – Forecast for CGM Transmitter Market Market (Million US$), 2023 – 2028
Figure-11: Germany – CGM User (Thousand), 2017 – 2023
Figure-12: Germany – Forecast for CGM User (Thousand),2023 – 2028
Figure-13: Germany – Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-14: Germany – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-15: Germany – Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-16: Germany – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-17: Germany – Test Strips Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-18: Germany – Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-19: Germany – Test Strips Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-20: Germany – Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-21: Germany – Lancet Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-22: Germany – Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-23: Germany – Lancet Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-24: Germany – Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-25: Germany – Meter Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-26: Germany – Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-27: Germany – Meter Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-28: Germany – Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-29: Germany – Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 – 2022
Figure-30: Germany – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 – 2028
Figure-31: Germany – Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 – 2022
Figure-32: Germany – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 – 2028
Figure-33: Germany – Disposable Insulin Pen Market (Million US$), 2017 – 2023
Figure-34: Germany – Forecast for Disposable Insulin Pen Market (Million US$), 2023 – 2028
Figure-35: Germany – Reusable Insulin Pen Market (Million US$), 2017 – 2023
Figure-36: Germany – Forecast for Reusable Insulin Pen Market (Million US$), 2023 – 2028
Figure-37: Germany – Smart Insulin Pen Market (Million US$), 2017 – 2023
Figure-38: Germany – Forecast for Smart Insulin Pen Market (Million US$), 2023 – 2028
Figure-39: Germany – Disposable Insulin Pen User (Thousand), 2017 – 2022
Figure-40: Germany – Forecast for Disposable Insulin Pen User (Thousand), 2023 – 2028
Figure-41: Germany – Reusable Insulin Pen User (Thousand), 2017 – 2022
Figure-42: Germany – Forecast for Reusable Insulin Pen User (Thousand), 2023 – 2028
Figure-43: Germany – Smart Insulin Pen User (Thousand), 2017 – 2022
Figure-44: Germany – Forecast for Smart Insulin Pen User (Thousand), 2023 – 2028
Figure-45: Germany – Insulin Pen Needle Market (Million US$), 2017 – 2023
Figure-46: Germany – Forecast for Pen Needle Market (Million US$), 2023 – 2028
Figure-47: Germany – Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-48: Germany – Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-49: Germany – Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-50: Germany – Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-51: Germany – Insulin Pump Type 1 Users (Thousand), 2017 – 2022
Figure-52: Germany – Forecast for Insulin Pump Type 1 Users (Thousand), 2023 – 2028
Figure-53: Germany – Insulin Pump Type 2 Users (Thousand), 2017 – 2022
Figure-54: Germany – Forecast for Insulin Pump Type 2 Users (Thousand), 2023 – 2028
Figure-55: B. Braun Melsungen AG – Global Revenue (Billion US$), 2017 – 2022
Figure-56: B. Braun Melsungen AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-57: Eli Lilly – Global Revenue (Million US$), 2017 – 2022
Figure-58: Eli Lilly – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-59: Terumo Corporation – Global Revenue (Billion US$), 2017 – 2022
Figure-60: Terumo Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-61: BD – Global Revenue (Billion US$), 2017 – 2022
Figure-62: BD – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-63: Novo Nordisk A/S – Global Revenue (Million US$), 2017 – 2022
Figure-64: Novo Nordisk A/S – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-65: Ypsomed AG – Global Revenue (Million US$), 2017 – 2022
Figure-66: Ypsomed AG – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-67: Medtronic – Global Revenue (Billion US$), 2017 – 2022
Figure-68: Medtronic – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-69: Insulet Corporation – Global Revenue (Million US$), 2017 – 2022
Figure-70: Insulet Corporation – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-71: DarioHealth Corp – Global Revenue (Million US$), 2017 – 2022
Figure-72: DarioHealth Corp – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-73: Abbott Laboratories – Global Revenue (Billion US$), 2017 – 2022
Figure-74: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-75: Dexcom Inc – Global Revenue (Million US$), 2017 – 2022
Figure-76: Dexcom Inc – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-77: Roche – Global Revenue (Billion US$), 2017 – 2022
Figure-78: Roche – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-79: Tandem Diabetes Care – Global Revenue (Million US$), 2017 – 2022
Figure-80: Tandem Diabetes Care – Forecast for Global Revenue (Million US$), 2023 – 2028
List of Tables:
Table-01: Germany – Diabetes Market Share by Type (Percent), 2017 – 2022
Table-02: Germany – Forecast for Diabetes Market Share by Type (Percent), 2023 – 2028

$2,990
$3,990

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings